Christine Neudorfl
Overview
Explore the profile of Christine Neudorfl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suerth J, Morgan M, Kloess S, Heckl D, Neudorfl C, Falk C, et al.
J Mol Med (Berl)
. 2023 Dec;
102(1):143-145.
PMID: 38057608
No abstract available.
2.
Hitz A, Blasing K, Wiegmann B, Bellmas-Sanz R, Chichelnitskiy E, Wandrer F, et al.
Front Immunol
. 2021 Dec;
12:778885.
PMID: 34966390
Introduction: For end-stage lung diseases, double lung transplantation (DLTx) is the ultimate curative treatment option. However, acute and chronic rejection and chronic dysfunction are major limitations in thoracic transplantation medicine....
3.
Hauser I, Marx S, Sommerer C, Suwelack B, Dragun D, Witzke O, et al.
Eur J Immunol
. 2020 Dec;
51(4):943-955.
PMID: 33306229
Post-transplant cytomegalovirus (CMV) infections and increased viral replication are associated with CMV-specific T-cell anergy. In the ATHENA-study, de-novo everolimus (EVR) with reduced-exposure tacrolimus (TAC) or cyclosporine (CyA) showed significant benefit...
4.
Kuhne J, Neudorfl C, Beushausen K, Keil J, Malysheva S, Wandrer F, et al.
Transpl Immunol
. 2020 Apr;
61:101291.
PMID: 32330566
Belatacept, Nulojix®, inhibits the interaction of CD28 on naïve T cells with B7.1/B7.2 (CD80/86) on antigen presenting cells, leading to T cell hyporesponsiveness and anergy and is approved as immunosuppressive...
5.
Egelkamp J, Chichelnitskiy E, Kuhne J, Wandrer F, Daemen K, Keil J, et al.
Am J Transplant
. 2019 May;
19(10):2692-2704.
PMID: 31062482
The role of endothelial cells in the pathophysiology of antibody-mediated rejection after renal transplantation has been widely investigated. We expand this scenario to the impact of epithelial cells on the...
6.
Cossarizza A, Chang H, Radbruch A, Akdis M, Andra I, Annunziato F, et al.
Eur J Immunol
. 2017 Oct;
47(10):1584-1797.
PMID: 29023707
No abstract available.
7.
Suerth J, Morgan M, Kloess S, Heckl D, Neudorfl C, Falk C, et al.
J Mol Med (Berl)
. 2015 Aug;
94(1):83-93.
PMID: 26300042
Unlabelled: Natural killer (NK) cells play an important role in tumor immunotherapy with their unique capability of killing transformed cells without the need for prior sensitization and without major histocompatibility...
8.
Hoffmann U, Neudorfl C, Daemen K, Keil J, Stevanovic-Meyer M, Lehner F, et al.
PLoS One
. 2015 Jul;
10(7):e0132484.
PMID: 26147651
To explore phenotype and function of NK cells in kidney transplant recipients, we investigated the peripheral NK cell repertoire, capacity to respond to various stimuli and impact of immunosuppressive drugs...
9.
Stassen M, Klein M, Becker M, Bopp T, Neudorfl C, Richter C, et al.
Mol Immunol
. 2006 May;
44(5):926-33.
PMID: 16650898
Mast cells are able to produce a huge panel of mediators including the Th2-type cytokine IL-9, which is considered to be a key mediator for the pathogenesis of allergic asthma,...
10.
Stassen M, Muller C, Richter C, Neudorfl C, Hultner L, Bhakdi S, et al.
Infect Immun
. 2003 Oct;
71(11):6171-7.
PMID: 14573633
Streptolysin O (SLO), a major virulence factor of pyogenic streptococci, binds to cholesterol in the membranes of eukaryotic cells and oligomerizes to form large transmembrane pores. While high toxin doses...